News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
219 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (29158)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (102)
4 (174)
5 (247)
6 (211)
7 (265)
8 (238)
11 (138)
12 (205)
13 (219)
14 (240)
15 (174)
18 (169)
19 (181)
20 (151)
21 (144)
22 (81)
23 (1)
25 (165)
26 (154)
27 (94)
28 (19)
29 (11)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
4
5
6
7
8
11
12
13
14
15
18
19
20
21
22
23
25
26
27
28
29
Press Releases
Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow
November 13, 2024
·
13 min read
Cancer
Syros Crashes Over 90% on Late-Stage MDS Fail, Loan Default
With the Phase III failure, Syros will discontinue the study of tamibarotene for myelodysplastic syndrome and will default on its loan from Oxford Finance LLC.
November 13, 2024
·
2 min read
·
Tristan Manalac
Obesity
Amgen Suffers Surprise Blow as New Bone Density Safety Concerns for MariTide Surface
Cantor Fitzgerald analyst Olivia Brayer found supplementary bone mineral density data for Amgen’s obesity candidate MariTide that could point to a potentially greater fracture risk than previously revealed, but some other analysts view the findings as a nonissue.
November 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
November 13, 2024
·
9 min read
Press Releases
Regeneron to Highlight Pioneering Pipeline Progress Across Multiple Modalities Spanning 10 Types of Blood Cancers and Disorders at ASH
November 13, 2024
·
17 min read
Press Releases
Predictive Oncology Reports Third Quarter 2024 Financial Results and Provides Strategic Update
November 13, 2024
·
9 min read
Press Releases
Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company
November 13, 2024
·
9 min read
Press Releases
Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 13, 2024
·
8 min read
Press Releases
Viracta Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 13, 2024
·
13 min read
Press Releases
BioRestorative Therapies Reports Positive Preliminary Phase 2 BRTX-100 Clinical Data
November 13, 2024
·
6 min read
Previous
13 of 22
Next
